12:00 AM
 | 
Oct 01, 2012
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Multiplicom sales and marketing update

Multiplicom launched genomic and somatic mutation detection kits based on its MASTR technology for investigational use. Separate MASTR kits were launched to detect genomic mutations for diseases including mucovisidosis, Marfan syndrome, Alport syndrome,...

Read the full 142 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >